VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report) during the second quarter, Holdings Channel.com reports. The fund bought 382,200 shares of the real estate investment trust’s stock, valued at approximately $7,048,000.
A number of other hedge funds have also added to or reduced their stakes in the stock. Bank of New York Mellon Corp grew its stake in Sabra Healthcare REIT by 1.8% in the 1st quarter. Bank of New York Mellon Corp now owns 4,114,215 shares of the real estate investment trust’s stock worth $71,875,000 after acquiring an additional 74,564 shares in the last quarter. Nuveen LLC purchased a new stake in shares of Sabra Healthcare REIT in the 1st quarter worth approximately $61,791,000. Advisors Capital Management LLC lifted its position in shares of Sabra Healthcare REIT by 20.5% in the 1st quarter. Advisors Capital Management LLC now owns 2,232,609 shares of the real estate investment trust’s stock worth $39,004,000 after purchasing an additional 380,505 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Sabra Healthcare REIT by 16.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,687,977 shares of the real estate investment trust’s stock worth $29,489,000 after purchasing an additional 243,274 shares during the period. Finally, Victory Capital Management Inc. lifted its position in shares of Sabra Healthcare REIT by 12.7% in the 1st quarter. Victory Capital Management Inc. now owns 1,630,076 shares of the real estate investment trust’s stock worth $28,477,000 after purchasing an additional 183,739 shares during the period. 99.40% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
SBRA has been the subject of several research reports. Truist Financial upped their price target on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a “hold” rating in a research report on Tuesday, September 2nd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, October 8th. JMP Securities increased their target price on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “market outperform” rating in a research report on Wednesday, August 6th. Wells Fargo & Company increased their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research report on Wednesday, August 27th. Finally, Scotiabank increased their target price on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the company a “sector perform” rating in a research report on Monday, June 23rd. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, Sabra Healthcare REIT currently has an average rating of “Moderate Buy” and an average target price of $20.88.
Sabra Healthcare REIT Stock Up 1.7%
NASDAQ:SBRA opened at $18.43 on Tuesday. The firm has a market capitalization of $4.42 billion, a P/E ratio of 24.25, a PEG ratio of 1.22 and a beta of 0.85. Sabra Healthcare REIT, Inc. has a 1-year low of $15.60 and a 1-year high of $20.03. The company’s fifty day moving average price is $18.68 and its 200-day moving average price is $18.20. The company has a debt-to-equity ratio of 0.91, a current ratio of 4.80 and a quick ratio of 4.80.
Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) last released its quarterly earnings data on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.02. The firm had revenue of $189.15 million for the quarter, compared to analyst estimates of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The business’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. As a group, equities research analysts anticipate that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current year.
Sabra Healthcare REIT Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 6.5%. The ex-dividend date was Friday, August 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 157.89%.
About Sabra Healthcare REIT
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Read More
- Five stocks we like better than Sabra Healthcare REIT
- Basic Materials Stocks Investing
- Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet
- What is a Stock Market Index and How Do You Use Them?
- 3 High-Yield Banks for Investors to Buy on the Dip
- Business Services Stocks Investing
- 5 Surprising Stocks Set to Benefit From a Future Robotics Boom
Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Healthcare REIT, Inc. (NASDAQ:SBRA – Free Report).
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.